First/Co-first Author Publications(*: Co-first Author)
2025-
Sequence-dependent splicing dysregulation drives therapy resistance in pediatric AML
Huang Y*, Xiao P*, Qin L*, Gao L*, Zhao Y, Sui J, Hu W, Zhou L, Han N, Lv X, Chen K, Liu Y, Lin H, Shen S, Abdel-Wahab O, Hu S, Liu Z, Wang Q
Science Translational Medicine•Under review
2025
Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors
Huang Y*, Guo J*, Han X*, Zhao Y, Li X, Xing P, Liu Y, Sun Y, Wu S, Lv X, Zhou L, Zhang YZ, Li C, Xie W, Liu Z
Nature Communications•Vol. 16•pp. 1552
2025
MRAS: Master Regulator analysis of Alternative Splicing
Zhou L*, Huang Y*, Zhao Y, Guo D, Wen X, Xu R, Lv X, Wu S, Jing S, Liu Z
Advanced Science•Under round 2 review
2023
ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers
Wu S*, Huang Y*, Zhang M, Gong Z, Wang G, Zheng X, Zong W, Zhao W, Xing P, Li R, Liu Z, Bao Y
Nucleic Acids Research•Vol. 51•pp. D1347-D1356
2024
RBMX Regulates YTHDC1 Nuclear Condensates to Promote Nascent Transcription in Acute Myeloid Leukemia
Wakiro I*, Huang Y*, Yang X, Xie X, Luo H, Chang K, Pierson A, Batchelor E, Cheng Y, Nguyen DTT, Liu Z, Kharas M
Blood•Vol. 144•pp. 627•The 66th ASH Annual Meeting Abstracts
Other Cooperative Publications
2024
Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome
Sui J, Guo D, Wen X, Zhou L, Huang Y, Yu H, Chen J, Liu Z
Advanced Science•Vol. 11•pp. e2405626
2022
DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
Zhang J, Huang J, Xu K, Xing P, Huang Y, Liu Z, Tong L, Manley JL
Proceedings of the National Academy of Sciences•Vol. 119•pp. e2216712119
Patents
2024
A method for subtyping pituitary tumors based on transcriptomic diversity
Huang Y, Liu Z, et al.
Patent No.: CN202410123456.7•Country: China